Cargando…
Roxadustat for treatment of anemia in a cancer patient with end-stage renal disease: A case report
BACKGROUND: Most cancer patients are accompanied by anemia, which will be more serious when combined with end-stage renal disease (ESRD). At present, cancer-related anemia and renal anemia treatments mainly include erythropoiesis-stimulating agents (ESAs), iron supplementation, and blood transfusion...
Autores principales: | Zhou, Qiao-Qiao, Li, Jing, Liu, Bin, Wang, Chun-Li |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9294907/ https://www.ncbi.nlm.nih.gov/pubmed/35979316 http://dx.doi.org/10.12998/wjcc.v10.i19.6587 |
Ejemplares similares
-
Roxadustat for treatment of erythropoietin-hyporesponsive anemia in a hemodialysis patient: A case report
por: Yu, Wei-Hong, et al.
Publicado: (2020) -
Roxadustat: Not just for anemia
por: Zhu, Xiaoyu, et al.
Publicado: (2022) -
Suppression of thyrotropin secretion during roxadustat treatment for renal anemia in a patient undergoing hemodialysis
por: Ichii, Mitsuru, et al.
Publicado: (2021) -
Efficacy of Roxadustat on anemia and residual renal function in patients new to peritoneal dialysis
por: Wu, Tong, et al.
Publicado: (2022) -
Comparison of efficacy of roxadustat and erythropoietin for the treatment of renal anemia in patients with chronic kidney disease: a retrospective study
por: Jin, Chen, et al.
Publicado: (2022)